Mindie H Nguyen

Mindie H Nguyen

UNVERIFIED PROFILE

Are you Mindie H Nguyen?   Register this Author

Register author
Mindie H Nguyen

Mindie H Nguyen

Publications by authors named "Mindie H Nguyen"

Are you Mindie H Nguyen?   Register this Author

100Publications

1754Reads

35Profile Views

The phosphatidylethanolamine biosynthesis pathway provides a new target for cancer chemotherapy.

J Hepatol 2020 Apr 22;72(4):746-760. Epub 2019 Nov 22.

Department of Anesthesia, Stanford University School of Medicine, Stanford, CA 94305. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.11.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085447PMC
April 2020

Only one-third of hepatocellular carcinoma cases are diagnosed via screening or surveillance: a systematic review and meta-analysis.

Eur J Gastroenterol Hepatol 2020 Mar;32(3):406-419

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0000000000001523DOI Listing
March 2020

Letter: a stepwise approach towards the screening of hepatic fibrosis in the general population-authors' reply.

Aliment Pharmacol Ther 2020 Mar;51(6):670-671

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.15664DOI Listing
March 2020

Editorial: choosing an appropriate risk stratification tool for nonalcoholic fatty liver disease-one size does not fit all. Authors' reply.

Aliment Pharmacol Ther 2020 Mar;51(6):662-663

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.15651DOI Listing
March 2020

Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy.

Clin Microbiol Rev 2020 Mar 26;33(2). Epub 2020 Feb 26.

UCL Medical School, Kings College Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/CMR.00046-19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048015PMC
March 2020

The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis.

Hepatol Int 2020 Mar 4. Epub 2020 Mar 4.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, 780 Welch Road, CJ250K, Palo Alto, CA, 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12072-020-10023-3DOI Listing
March 2020

Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis.

Eur J Clin Pharmacol 2020 Mar 14. Epub 2020 Mar 14.

Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, 1225 Center Drive, Gainesville, 32610, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-020-02854-8DOI Listing
March 2020

Chronic Hepatitis B Prevalence Among Foreign-Born and U.S.-Born Adults in the United States, 1999-2016.

Hepatology 2020 Feb 13;71(2):431-443. Epub 2019 Aug 13.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.30831DOI Listing
February 2020

Letter to the Editor: Chronic Hepatitis B and Nonalcoholic Steatohepatitis: Is "Fat" All Bad?

Hepatology 2020 Feb 26;71(2):768. Epub 2020 Jan 26.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.30983DOI Listing
February 2020

Inhibitory Effect of Nucleos(t)ide Analogs on Telomerase Activity and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.

Am J Gastroenterol 2020 Feb;115(2):302-303

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14309/ajg.0000000000000507DOI Listing
February 2020

Prevalence of significant hepatic fibrosis using magnetic resonance elastography in a health check-up clinic population.

Aliment Pharmacol Ther 2020 Feb;51(3):388-396

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.15626DOI Listing
February 2020

Fatty liver is not independently associated with the rates of complete response to oral antiviral therapy in chronic hepatitis B patients.

Liver Int 2020 Feb 22. Epub 2020 Feb 22.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.14415DOI Listing
February 2020

Prevalence of Viremic Hepatitis C Virus Infection by Age, Race/Ethnicity, and Birthplace and Disease Awareness Among Viremic Persons in the United States, 1999-2016.

J Infect Dis 2020 Jan;221(3):408-418

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiz479DOI Listing
January 2020

Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study.

J Intern Med 2019 Dec 23;286(6):711-722. Epub 2019 Aug 23.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/joim.12964DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851415PMC
December 2019

Letter to the Editor: Prevalence of NAFLD in China: What Did We Learn From the Recent Meta-Analysis?

Hepatology 2019 Dec;70(6):2238-2239

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.30892DOI Listing
December 2019

Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis.

Eur J Gastroenterol Hepatol 2019 Dec 24. Epub 2019 Dec 24.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0000000000001639DOI Listing
December 2019

Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis.

Aliment Pharmacol Ther 2019 11 16;50(9):1037-1048. Epub 2019 Sep 16.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.15499DOI Listing
November 2019

Nonalcoholic Fatty Liver Disease and Renal Function Impairment: A Cross-Sectional Population-Based Study on Its Relationship From 1999 to 2016.

Hepatol Commun 2019 Oct 29;3(10):1334-1346. Epub 2019 Jul 29.

Division of Gastroenterology and Hepatology Stanford University Medical Center Palo Alto CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep4.1408DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771162PMC
October 2019

A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA.

Dig Dis Sci 2019 Oct 9. Epub 2019 Oct 9.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, 750 Welch Road, Suite 210, Palo Alto, CA, 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-019-05869-zDOI Listing
October 2019

Low Alanine Aminotransferase Cut-Off for Predicting Liver Outcomes; A Nationwide Population-Based Longitudinal Cohort Study.

J Clin Med 2019 Sep 11;8(9). Epub 2019 Sep 11.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto 94305, CA, USA.

View Article

Download full-text PDF

Source
https://www.mdpi.com/2077-0383/8/9/1445
Publisher Site
http://dx.doi.org/10.3390/jcm8091445DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780691PMC
September 2019

Nonliver Comorbidities in Patients With Chronic Hepatitis B.

Clin Liver Dis (Hoboken) 2019 Sep 9;14(3):126-130. Epub 2019 Oct 9.

Department of Medicine Division of Gastroenterology and Hepatology Stanford University Palo Alto CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cld.829DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784802PMC
September 2019

Associations Between Body Fat, Muscle Mass, and Nonalcoholic Fatty Liver Disease: A Population-Based Study.

Hepatol Commun 2019 Aug 27;3(8):1061-1072. Epub 2019 Jun 27.

Center for Policy, Outcomes and Prevention Stanford University School of Medicine Stanford CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep4.1392DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6671685PMC
August 2019

Antiviral therapy and the development of osteopenia/osteoporosis among Asians with chronic hepatitis B.

J Med Virol 2019 07 27;91(7):1288-1294. Epub 2019 Feb 27.

Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University, Palo Alto, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmv.25433DOI Listing
July 2019

Reduced Hepatocellular Carcinoma Risk vs Bleeding Risk Associated With Aspirin.

JAMA Oncol 2019 06;5(6):911

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California.

View Article

Download full-text PDF

Source
http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jam
Publisher Site
http://dx.doi.org/10.1001/jamaoncol.2019.0614DOI Listing
June 2019

Comparison of renal safety of tenofovir and entecavir in patients with chronic hepatitis B: Systematic review with meta-analysis.

World J Gastroenterol 2019 Jun;25(23):2961-2972

Department of Internal Medicine, Hanyang University College of Medicine, Seoul 04763, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v25.i23.2961DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589741PMC
June 2019

Correction to: Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.

Dig Dis Sci 2019 May;64(5):1392-1394

Department of Gastroenterology, Kaiser Permanente, Northern California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10620-019-05558-x
Publisher Site
http://dx.doi.org/10.1007/s10620-019-05558-xDOI Listing
May 2019

Reply.

Gastroenterology 2019 May 28. Epub 2019 May 28.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2019.05.046DOI Listing
May 2019

Changes in Renal Function in Patients With Chronic HBV Infection Treated With Tenofovir Disoproxil Fumarate vs Entecavir.

Clin Gastroenterol Hepatol 2019 04 18;17(5):948-956.e1. Epub 2018 Aug 18.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15423565183087
Publisher Site
http://dx.doi.org/10.1016/j.cgh.2018.08.037DOI Listing
April 2019

Prevalence of Undetectable Vaccine-Induced Immunity Against Hepatitis B Virus in US Adults at High Risk for Infection.

Hepatology 2019 Apr 20;69(4):1385-1397. Epub 2019 Feb 20.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.30285DOI Listing
April 2019

Poor Adherence to Guidelines for Treatment of Chronic Hepatitis B Virus Infection at Primary Care and Referral Practices.

Clin Gastroenterol Hepatol 2019 04 13;17(5):957-967.e7. Epub 2018 Oct 13.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2018.10.012DOI Listing
April 2019

Hepatitis B and renal function: A matched study comparing non-hepatitis B, untreated, treated and cirrhotic hepatitis patients.

Liver Int 2019 04 18;39(4):655-666. Epub 2018 Dec 18.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.14009DOI Listing
April 2019

Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis.

Korean J Intern Med 2019 Mar 20;34(2):296-304. Epub 2018 Mar 20.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3904/kjim.2017.194DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406097PMC
March 2019

Rising Inpatient Encounters and Economic Burden for Patients with Nonalcoholic Fatty Liver Disease in the USA.

Dig Dis Sci 2019 03 16;64(3):698-707. Epub 2018 Oct 16.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, 300 Pasteur Dr A160 MC 5309, Stanford, CA, 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-018-5326-7DOI Listing
March 2019

Reply.

Authors:
Mindie H Nguyen

Hepatology 2019 Feb 14. Epub 2019 Feb 14.

Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.30560DOI Listing
February 2019

Individual surveillance using model-based hepatocellular carcinoma risk estimates in chronic hepatitis C patients after antiviral treatment.

J Hepatol 2019 01 15;70(1):209-211. Epub 2018 Oct 15.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.09.016DOI Listing
January 2019

Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk.

Aliment Pharmacol Ther 2019 01 19;49(1):107-115. Epub 2018 Nov 19.

Division of Gastroenterology and Hepatology, Fu-Jen Catholic University Hospital, New Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/apt.15058
Publisher Site
http://dx.doi.org/10.1111/apt.15058DOI Listing
January 2019

Sustained virologic response rates in patients with chronic hepatitis C genotype 6 treated with ledipasvir+sofosbuvir or sofosbuvir+velpatasvir.

Aliment Pharmacol Ther 2019 01 22;49(1):99-106. Epub 2018 Nov 22.

Division of Gastroenterology and Hepatology, Stanford University, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.15043DOI Listing
January 2019

Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B.

Aliment Pharmacol Ther 2018 11 10;48(10):1128-1137. Epub 2018 Oct 10.

Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/apt.15006
Publisher Site
http://dx.doi.org/10.1111/apt.15006DOI Listing
November 2018

Effects of Treatment of Chronic Hepatitis B Virus Infection on Patient-Reported Outcomes.

Clin Gastroenterol Hepatol 2018 10 2;16(10):1641-1649.e6. Epub 2018 Mar 2.

Center for Outcomes Research in Liver Disease, Washington, District of Columbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2018.02.037DOI Listing
October 2018

A New Concept: Pre-HCC Disease.

Hepatology 2018 10;68(4):1662

Department of Gastroenterology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.30154DOI Listing
October 2018

Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.

Dig Dis Sci 2018 Sep 19;63(9):2267-2274. Epub 2018 Feb 19.

Department of Gastroenterology, Kaiser Permanente, Northern California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-018-4964-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097881PMC
September 2018

Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis.

PLoS One 2018 30;13(4):e0196452. Epub 2018 Apr 30.

Stanford University Medical Center, Division of Gastroenterology and Hepatology, Palo Alto, CA, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0196452PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927421PMC
August 2018

Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in Asia.

BMJ Open Gastroenterol 2018 20;5(1):e000209. Epub 2018 Aug 20.

Division of Gastroenterology and Hepatology, Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjgast-2018-000209DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104766PMC
August 2018

Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy.

Drug Des Devel Ther 2017 6;11:3197-3204. Epub 2017 Nov 6.

Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University Medical Center, Palo Alto, CA, USA.

View Article

Download full-text PDF

Source
https://www.dovepress.com/tenofovir-alafenamide-in-the-treat
Publisher Site
http://dx.doi.org/10.2147/DDDT.S126742DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683768PMC
July 2018

Higher mortality and hospital charges in patients with cirrhosis and acute respiratory illness: a population-based study.

Sci Rep 2018 07 2;8(1):9969. Epub 2018 Jul 2.

Stanford University Medical Center, Division of Gastroenterology and Hepatology, Palo Alto, CA, 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-28317-wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028654PMC
July 2018

Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.

Cancer 2018 06 6;124(12):2588-2598. Epub 2018 Apr 6.

Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University Medical Center, Palo Alto, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31373DOI Listing
June 2018

Author response to "Cryptogenic hepatocellular carcinoma (HCC) had worse overall survival of disease than viral HCC patients".

Liver Int 2018 06;38(6):1141

Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13680DOI Listing
June 2018

Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California.

Hepatol Med Policy 2018 5;3. Epub 2018 Jun 5.

2Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University Medical Center, Palo Alto, CA USA.

View Article

Download full-text PDF

Source
https://hmap.biomedcentral.com/articles/10.1186/s41124-018-0
Publisher Site
http://dx.doi.org/10.1186/s41124-018-0034-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987626PMC
June 2018

More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.

Liver Int 2018 05 3;38(5):895-902. Epub 2017 Nov 3.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13613DOI Listing
May 2018

Higher risk of hepatocellular carcinoma in Hispanic patients with hepatitis C cirrhosis and metabolic risk factors.

Sci Rep 2018 05 8;8(1):7164. Epub 2018 May 8.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-25533-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940826PMC
May 2018

Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations.

BMJ Open Gastroenterol 2018 5;5(1):e000203. Epub 2018 May 5.

Division of Gastroenterology and Hepatology, Stanford University, Palo Alto, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjgast-2018-000203DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942460PMC
May 2018

Serum Aminotransferase Flares in Pregnant and Postpartum Women With Current or Prior Treatment for Chronic Hepatitis B.

J Clin Gastroenterol 2018 03;52(3):255-261

Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCG.0000000000000822DOI Listing
March 2018

Hepatocellular carcinoma decreases the effectiveness of hepatitis C antiviral treatment: Do direct-acting antiviral regimens matter?

Hepatology 2018 03 30;67(3):1180-1182. Epub 2018 Jan 30.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hep.29701
Publisher Site
http://dx.doi.org/10.1002/hep.29701DOI Listing
March 2018

Increasing co-morbidities in chronic hepatitis B patients: experience in primary care and referral practices during 2000-2015.

Clin Transl Gastroenterol 2018 Mar 14;9(3):141. Epub 2018 Mar 14.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford University, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=01720094-201803000-0000
Publisher Site
http://dx.doi.org/10.1038/s41424-018-0007-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862154PMC
March 2018

Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis.

Expert Rev Gastroenterol Hepatol 2017 Dec 7;11(12):1095-1104. Epub 2017 Aug 7.

b Division of Gastroenterology and Hepatology , Stanford University Medical Center , Palo Alto , CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474124.2017.1361822DOI Listing
December 2017

Open Label Study of 8 vs. 12 Weeks of Ledipasvir/Sofosbuvir in Genotype 6 Treatment Naïve or Experienced Patients.

Am J Gastroenterol 2017 Dec 31;112(12):1824-1831. Epub 2017 Oct 31.

Stanford University Medical Center, Stanford, Caliornia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2017.399DOI Listing
December 2017

Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience.

BMJ Open Gastroenterol 2017 20;4(1):e000181. Epub 2017 Dec 20.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjgast-2017-000181DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759739PMC
December 2017

Tenofovir alafenamide as compared to tenofovir disoproxil fumarate in the management of chronic hepatitis B with recent trends in patient demographics.

Expert Rev Gastroenterol Hepatol 2017 Nov 8;11(11):999-1008. Epub 2017 Oct 8.

e Division of Gastroenterology and Hepatology , Stanford University Medical Center , Palo Alto , CA , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17474124.2017.1
Publisher Site
http://dx.doi.org/10.1080/17474124.2017.1386554DOI Listing
November 2017

Management of Chronic Hepatitis B in Pregnancy.

J Clin Gastroenterol 2017 Oct;51(9):789-795

*Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto ‡Department of Liver Transplant, Cedars Sinai Medical Center, Los Angeles, CA †Department of Infectious Disease, Shandong Provincial Hospital Affiliated to Shandong University, Ji'nan, Shandong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCG.0000000000000908DOI Listing
October 2017

Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.

Ann Surg 2017 09;266(3):525-535

*Dumont-UCLA Liver Transplant and Cancer Centers, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA †Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX ‡Recanati/Miller Transplantation Institute, Mount Sinai Medical Center, New York, NY §Penn Transplant Institute, University of Pennsylvania, Philadelphia, PA ¶Department of Transplantation, Mayo Clinic, Jacksonville, FL ||New York Presbyterian Hospital, Columbia University, New York, NY **New York Presbyterian Hospital, Weill Cornell, New York, NY ††Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA ‡‡Cleveland Clinic Foundation, Cleveland, OH §§Section of Transplantation, Department of Surgery, Washington University in St. Louis, St. Louis, MO ¶¶Division of Gastroenterology and Hepatology, Stanford University, Palo Alto, CA ||||Department of Surgery, Stanford University, Palo Alto, CA ***Division of Transplant Surgery, Department of Surgery, University of Colorado School of Medicine, Denver, CO †††Sherrie & Alan Conover Center for Liver Disease & Transplantation, Houston Methodist Hospital, Houston, TX ‡‡‡Division of Transplant Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA §§§Department of Surgery, University of Nebraska Medical Center, Omaha, NE ¶¶¶Division of Transplantation and Hepatobiliary Surgery, Department of Surgery, University of California, San Diego, San Diego, CA ||||||Department of Surgery, Duke University Medical Center; Durham, NC ****Division of Transplant Surgery, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI ††††Department of Surgery, Baylor College of Medicine, Houston, TX ‡‡‡‡Section of Hepatobiliary and Transplant Surgery, University of Louisville School of Medicine, Louisville, KY §§§§Medstar Georgetown Transplant Institute, Georgetown University, Washington, District of Columbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0000000000002381DOI Listing
September 2017

Ledipasvir and sofosbuvir combination for hepatitis C virus infection in three patients aged 85 years and older.

Eur J Gastroenterol Hepatol 2017 08;29(8):977-979

aDepartment of Infectious Diseases bShaanxi Provincial Clinical Research Center for Hepatic and Splenic Diseases cNational and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China dDivision of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0000000000000873DOI Listing
August 2017

Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.

PLoS One 2017 27;12(3):e0173499. Epub 2017 Mar 27.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0173499PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367688PMC
August 2017

HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.

Am J Gastroenterol 2017 Jul 25;112(7):1111-1119. Epub 2017 Apr 25.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2017.123DOI Listing
July 2017

Epidemiology of hepatitis B and the role of vaccination.

Best Pract Res Clin Gastroenterol 2017 Jun 6;31(3):239-247. Epub 2017 Jun 6.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, 300 Pasteur Drive, Palo Alto, CA 94304, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15216918173004
Publisher Site
http://dx.doi.org/10.1016/j.bpg.2017.05.008DOI Listing
June 2017

Increased Prevalence of Metabolic Risk Factors in Asian Americans With Hepatocellular Carcinoma.

J Clin Gastroenterol 2017 Apr;51(4):384-390

*Department of Medicine §School of Medicine †Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA ‡Washington University in St. Louis, St. Louis, MO ∥Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCG.0000000000000689DOI Listing
April 2017

Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease.

Medicine (Baltimore) 2017 Feb;96(6):e6128

aGastroenterology and Hepatology, Stanford University Medical Center, Palo Alto bUniversity of California, Los Angeles School of Medicine, Los Angeles, CA cDepartment of Cirrhosis, Institute of Liver Disease, Shuguang Hospital, Shanghai University of T.C.M., Shanghai, P.R. China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000006128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313031PMC
February 2017

Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States.

Cancer 2017 Jan 29;123(1):81-89. Epub 2016 Aug 29.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161593PMC
January 2017

Screening and management of viral hepatitis and hepatocellular carcinoma in Mongolia: results from a survey of Mongolian physicians from all major provinces of Mongolia.

BMJ Open Gastroenterol 2016 10;3(1):e000119. Epub 2016 Nov 10.

Division of Gastroenterology and Hepatology, Stanford University, Stanford, California, USA; Center for Innovation in Global Health, Stanford University, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjgast-2016-000119DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5128837PMC
November 2016

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.

World J Gastroenterol 2016 Oct;22(37):8294-8303

Carrie R Wong, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v22.i37.8294DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055860PMC
October 2016

Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment.

Clin Mol Hepatol 2016 Sep 25;22(3):327-335. Epub 2016 Sep 25.

Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3350/cmh.2016.0049DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066376PMC
September 2016

Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B.

Medicine (Baltimore) 2016 Aug;95(35):e4744

aPublic Policy Department, Stanford University, Stanford, CA bDepartment of Medicine, Stanford University Medical Center, Palo Alto, CA cDivision of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA dDepartment of Biology, Stanford University, Stanford, CA eDepartment of Cirrhosis, Institute of Liver Disease, Shuguang Hospital, Shanghai University of T.C.M., Shanghai, P.R. China fDepartment of Medicine, Yale University Medical Center, New Haven, CT gDepartment of Medicine, University of California, San Diego Medical Center, San Diego, CA hDepartment of Gastroenterology, Palo Alto Medical Foundation, Palo Alto, CA iDepartment of Outpatient Clinics, Chinese Hospital, San Francisco, CA jSan Jose Gastroenterology, San Jose, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000004744DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008605PMC
August 2016